Brief: Inflarx Reports Cash And Cash Equivalents Plus Securities And Other Investments Of EUR 138.3 Million As Of June 30
14/08/2019 21:28
Aug 14 (Reuters) - Inflarx NV IF0G.F :
* INFLARX REPORTS SECOND QUARTER 2019 FINANCIAL & OPERATING
RESULTS
* CASH AND CASH EQUIVALENTS PLUS SECURITIES AND OTHER
INVESTMENTS
OF EUR 138.3 MILLION AS OF JUNE 30, 2019
* H1 LOSS PER SHARE EUR 0.97
* Q2 EARNINGS PER SHARE VIEW EUR -0.47 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX4DYyR6
Further company coverage: IF0G.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inflarx NV
See all newsBrief: Inflarx NV Files For Offerng Of Ordinary Shares, Size Not Disclosed - SEC Filing
Brief: InflaRx Reports Full Year 2025 Results And Highlights Key Achievements And Expected Milestones
Brief: Inflarx Announces Late-Breaker Oral Presentation On Vilobelimab Phase 3 Results In Pyoderma Gangrenosum At 2026 American Academy Of Dermatology Annual Meeting
Brief: Inflarx NV Executing 30% Workforce Reduction
Brief: Inflarx Provides Update On Phase 3 Data Analyses For Vilobelimab In Pyoderma Gangrenosum